STOCKHOLM, Dec. 3, 2024 /PRNewswire/ — ASSA ABLOY has acquired 9Solutions, a Finnish provider of highly integrated AI-powered real time locating healthcare solutions for critical communication and collaboration, with a focus on senior care. “I am very pleased to welcome 9Solutions into the ASSA ABLOY Group, an exciting technological addition that will reinforce our current… Continue reading ASSA ABLOY acquires 9Solutions in Finland
Tag: People
ASSA ABLOY acquires 9Solutions in Finland
STOCKHOLM, Dec. 3, 2024 /PRNewswire/ — ASSA ABLOY has acquired 9Solutions, a Finnish provider of highly integrated AI-powered real time locating healthcare solutions for critical communication and collaboration, with a focus on senior care. “I am very pleased to welcome 9Solutions into the ASSA ABLOY Group, an exciting technological addition that will reinforce our current… Continue reading ASSA ABLOY acquires 9Solutions in Finland
Today Essity hosts its Capital Markets Day – Accelerating Profitable Growth
STOCKHOLM, Dec. 3, 2024 /PRNewswire/ — Today Essity hosts its Capital Markets Day at the company’s production facility for hygiene products in Valls, Spain. Essity will present its strategy for accelerating profitable growth and the roadmap to achieving the company’s financial targets, which were announced on June 17, 2024. The day will also include a… Continue reading Today Essity hosts its Capital Markets Day – Accelerating Profitable Growth
Today Essity hosts its Capital Markets Day – Accelerating Profitable Growth
STOCKHOLM, Dec. 3, 2024 /PRNewswire/ — Today Essity hosts its Capital Markets Day at the company’s production facility for hygiene products in Valls, Spain. Essity will present its strategy for accelerating profitable growth and the roadmap to achieving the company’s financial targets, which were announced on June 17, 2024. The day will also include a… Continue reading Today Essity hosts its Capital Markets Day – Accelerating Profitable Growth
Genethon and Hansa Biopharma announce initiation of a Phase 2 trial of imlifidase as a pre-treatment to GNT-0003 in severe Crigler-Najjar syndrome
The trial will be conducted in patients with pre-existing anti-AAV antibodies which limit use of gene therapy treatment. LUND, Sweden and EVRY, France, Dec. 3, 2024 /PRNewswire/ — Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA) and Genethon, a pioneer and a leader in gene therapy research and development for rare genetic diseases, today announced initiation of… Continue reading Genethon and Hansa Biopharma announce initiation of a Phase 2 trial of imlifidase as a pre-treatment to GNT-0003 in severe Crigler-Najjar syndrome
Genethon and Hansa Biopharma announce initiation of a Phase 2 trial of imlifidase as a pre-treatment to GNT-0003 in severe Crigler-Najjar syndrome
The trial will be conducted in patients with pre-existing anti-AAV antibodies which limit use of gene therapy treatment. LUND, Sweden and EVRY, France, Dec. 3, 2024 /PRNewswire/ — Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA) and Genethon, a pioneer and a leader in gene therapy research and development for rare genetic diseases, today announced initiation of… Continue reading Genethon and Hansa Biopharma announce initiation of a Phase 2 trial of imlifidase as a pre-treatment to GNT-0003 in severe Crigler-Najjar syndrome
Global Times: Xi stresses comprehensively advancing high-quality Belt and Road cooperation
BEIJING, Dec. 2, 2024 /PRNewswire/ — Chinese President Xi Jinping on Monday stressed comprehensively advancing high-quality cooperation under the Belt and Road Initiative (BRI). Xi, also general secretary of the Communist Party of China Central Committee and chairman of the Central Military Commission, made the remarks when addressing a symposium on BRI development, according to the… Continue reading Global Times: Xi stresses comprehensively advancing high-quality Belt and Road cooperation
EPAM Completes Strategic Acquisition of First Derivative, Enhancing AI and Data-Driven Solutions for Financial Services
Strategic acquisition strengthens EPAM’s financial services delivery capabilities in North America, Europe and APAC, enhancing end-to-end services NEWTOWN, Pa. and NEWRY, N. Ireland, Dec. 3, 2024 /PRNewswire/ — EPAM Systems, Inc. (NYSE: EPAM), a leading digital transformation services and product engineering company, today announced the successful completion of its acquisition of First Derivative, a Northern Ireland-headquartered… Continue reading EPAM Completes Strategic Acquisition of First Derivative, Enhancing AI and Data-Driven Solutions for Financial Services
EPAM Completes Strategic Acquisition of First Derivative, Enhancing AI and Data-Driven Solutions for Financial Services
Strategic acquisition strengthens EPAM’s financial services delivery capabilities in North America, Europe and APAC, enhancing end-to-end services NEWTOWN, Pa. and NEWRY, N. Ireland, Dec. 3, 2024 /PRNewswire/ — EPAM Systems, Inc. (NYSE: EPAM), a leading digital transformation services and product engineering company, today announced the successful completion of its acquisition of First Derivative, a Northern Ireland-headquartered… Continue reading EPAM Completes Strategic Acquisition of First Derivative, Enhancing AI and Data-Driven Solutions for Financial Services
ATRenew Inc. Included in UNGC’s Forward Faster Campaign for Sustainable Development Contributions in China’s Private Sector
SHANGHAI, Dec. 3, 2024 /PRNewswire/ — ATRenew Inc. (“ATRenew” or the “Company”) (NYSE: RERE), a leading technology-driven pre-owned consumer electronics transactions and services platform in China, today announced it has been recognized by the United Nations Global Compact’s (“UNGC”) “Forward Faster: 20 Examples of Private Sector’s Sustainable Development in China” campaign (the “Campaign”). This prestigious… Continue reading ATRenew Inc. Included in UNGC’s Forward Faster Campaign for Sustainable Development Contributions in China’s Private Sector